The diagnostic approach to prostate cancer is still a big challenge for the treating physician.
Regarding an individualized and risk-adapted evaluation of different therapeutic options, precise diagnostic tools are crucial to accurately distinguish between localized and advanced prostate cancer. Imaging of advanced prostate cancer is currently changing due to numerous technical innovations. While choline-based hybrid positron emission tomography-computed tomography (PET/CT) has been established as an important diagnostic tool in clinical imaging of advanced prostate cancer, well-investigated methods, such as magnetic resonance imaging (MRI) and bone scintigraphy are currently expanding the diagnostic potential due to technical improvements. The specific use of imaging for advanced prostate cancer may help to offer the patient a well-tailored oncologic therapy. Further research is needed to evaluate whether this individualized therapy can consistently improve the prognosis of patients suffering from advanced prostate cancer.
Written by:
Kretschmer A, Seitz M, Graser A, Stief CG, Tilki D. Are you the author?
Urologische Klinik und Poliklinik, Ludwig-Maximilians-Universität München, Marchioninistraße 15, 81377, München, Deutschland.
Reference: Urologe A. 2013 Apr;52(4):497-503.
doi: 10.1007/s00120-012-3095-z
PubMed Abstract
PMID: 23483268
Article in German.
UroToday.com Prostate Cancer Section
